HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A double blind study of the new hypolipidemic agent pirozadil (722-D) using patients with ischemic heart disease (author's transl)].

AuthorsM Cadierno Carpintero, E Emeterio Reig, J M Soler Masana
JournalMedicina clinica (Med Clin (Barc)) Vol. 78 Issue 9 Pg. 386-9 (May 01 1982) ISSN: 0025-7753 [Print] Spain
Vernacular TitleEstudio doble ciego con un nuevo producto hipolipidemiante, el pirozadil (722-D), desde el punto de vista comparativo con alufibrato en enfermos afectos de cardiopatía isquémica.
PMID7047927 (Publication Type: Clinical Trial, Comparative Study, English Abstract, Journal Article, Randomized Controlled Trial)
Chemical References
  • Hypolipidemic Agents
  • Pyridines
  • alfibrate
  • Clofibric Acid
  • pirozadil
Topics
  • Aged
  • Clinical Trials as Topic
  • Clofibric Acid (analogs & derivatives, therapeutic use)
  • Coronary Disease (drug therapy)
  • Double-Blind Method
  • Female
  • Humans
  • Hypolipidemic Agents (therapeutic use)
  • Male
  • Middle Aged
  • Pyridines (therapeutic use)
  • Random Allocation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: